Congenital amegakaryocytic thrombocytopenia (CAMT) - A defect of the thrombopoietin receptor c-Mpl;Kongenitale amegakaryozytäre thrombozytopenie (CAMT) - Ein defekt des thrombopoetinrezeptors c-Mpl

Klinische Padiatrie

Volumn 213, Issue 4, 2001, Pages 155-161

  Germeshausen, M ^a   Schulze, H ^a   Gaudig, A ^a   Krukemeier, S ^a   Strauss G ^a   Welte, K ^a   Ballmaier, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

c Mpl; Congenital amegakaryocytic thrombocytopenia; Hematopoiesis; Pancytopenia; TPO

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR;

ARTICLE; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; DISEASE COURSE; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PANCYTOPENIA; PATHOGENESIS; PROTEIN BLOOD LEVEL; SYNDROME; THROMBOCYTE; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD PLATELETS; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; MUTATION; NEOPLASM PROTEINS; PANCYTOPENIA; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 0034878066     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16846     Document Type: Article

References (42)

1. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl
2. The bone marrow failure syndromes
3. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin
4. Defective TPO-reactivity in congenital amegakaryocytic thrombocytopenia
5. c-mpl Mutations are the cause of congenital amegakaryocytic thrombocytopenia
6. Response: Screening for c-mpl mutations in patients with congenital amegakaryocytic thrombocytopenia identifies a polymorphism
7. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl
8. - bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin
9. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice
10. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis
11. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis
12. Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias
13. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c- Mpl ligand
14. Thrombopoietin Acts Synergistically on Ca(2+) Mobilization in Platelets Caused by ADP or Thrombin Receptor Agonist Peptide
15. Congenital amegakaryocytic thrombocytopenia: An intrinsic hematopoietic stem cell defect
16. Inherited bone marrow failure syndromes
17. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia
18. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura
19. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia
20. Purification and characterization of thrombopoietin
21. Thrombopoietin: The primary regulator of platelet production
22. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin
23. Thrombopoietin supports proliferaton of human primitive hematopoietic cells in synergy with stell factor and/or interleukin-3
24. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice
25. The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production
26. The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit
27. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
28. Oligodeoxynucleotides antisense to the protooncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis
29. Structure and transcription of the human c-mpl gene (MPL)
30. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera
31. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura
32. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis
33. Familial dyserythropoietic anaemia and thrombocytotopenia dua to an in inherited mutation in GATA1
34. Aplastic anemia in childhood. III. Constitutional aplastic anaemia and related cytopenias
35. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells
36. Murine c-mpl: A member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal
37. Role of c-mpl in early hematopoiesis
38. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors
39. Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets
40. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia
41. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily
42. Characterization of the murine Mpl protooncogene, a member of the hematopoietic cytokine receptor family: Molecular cloning, chromosomal location and evidence for a function in cell growth